DNA methylation and healthy human aging.
Jones MJ, Goodman SJ, Kobor MS. · 2015
Read DNA methylation and healthy human aging. by Jones MJ, Goodman SJ, Kobor MS. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4693469.txt.
Introduction
Meaghan J. Jones, Sarah J. Goodman, and Michael S. Kobor reviewed DNA methylation and healthy aging in Aging Cell in 2015. Methylation means small chemical tags placed on DNA, often near gene switches, that track with gene activity. These patterns shift across a lifetime. Early work showed overall tag levels rising in childhood and falling late in life. Newer tools let researchers watch single sites instead.
Two patterns emerged. Some sites drift apart with age, varying more and more between people. Other sites change so steadily that a small set can predict a donor's age, a finding called the epigenetic clock. The review weighs how genes, surroundings, and these tags interact to set the pace of aging. It also notes cautions for studies that use epigenetic age as a health measure. The field, the authors show, is young but moving fast.
Catalog record
| CREATOR | Jones MJ, Goodman SJ, Kobor MS. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
DNA methylation and healthy human aging By Meaghan J Jones, Sarah J Goodman, Michael S Kobor Published in: Aging Cell DOI: 10.1111/acel.12349 ABSTRACT Summary The process of aging results in a host of changes at the cellular and molecular levels, which include senescence, telomere shortening, and changes in gene expression. Epigenetic patterns also change over the lifespan, suggesting that epigenetic changes may constitute an important component of the aging process. The epigenetic mark that has been most highly studied is DNA methylation, the presence of methyl groups at CpG dinucleotides. These dinucleotides are often located near gene promoters and associate with gene expression levels. Early studies indicated that global levels of DNA methylation increase over the first few years of life and then decrease beginning in late adulthood. Recently, with the advent of microarray and next‐generation sequencing technologies, increases in variability of DNA methylation with age have been observed, and a number of site‐specific patterns have been identified. It has also been shown that certain CpG sites are highly associated with age, to the extent that prediction models using a small number of these sites can accurately predict the chronological age of the donor. Together, these observations point to the existence of two phenomena that both contribute to age‐related DNA methylation changes: epigenetic drift and the epigenetic clock. In this review, we focus on healthy human aging throughout the lifetime and discuss the dynamics of DNA methylation as well as how interactions between the genome, environment, and the epigenome influence aging rates. We also discuss the impact of determining ‘epigenetic age’ for human health and outline some important caveats to existing and future studies. Keywords: aging, DNA methylation, epigenetics, human, review INTRODUCTION The biology of aging has been a consistent source of interest among the public and researchers alike. Main questions for exploration include what happens to result in the host of phenomena associated with age and what strategies can slow this progression. Beginning at birth, developmental programs result in age‐related changes to gene expression, growth, and physiology. Over the entire life course, these changes can be seen in physical manifestations, especially in advanced age with its associated functional declines caused by the accumulation of cellular damage, paired with a diminished ability to repair this damage (Lopez‐Otin et al., 2013). One phenomenon associated with aging is a change in patterns of epigenetic modifications. Epigenetics is most commonly defined as modifications to DNA and DNA packaging that do not involve changes to the DNA sequence and that are potentially transmissible to daughter cells (Bird, 2007). Given its dynamic nature, epigenetics has been referred to as the interface between the genome and the environment (Feil & Fraga, 2012). Epigenetics includes modifications to histone proteins, noncoding RNAs, and DNA methylation; here, we focus on the latter as it is a more accessible mark for quantitative measurements and thus is more often used in human population studies. The most common form of DNA methylation involves the addition of a methyl group to the 5′ cytosine of C‐G dinucleotides, referred to as CpGs. These nucleotide pairs are relatively sparse in the genome, and areas of comparatively high CpG density are referred to as CpG islands, identified as regions > 200 bp with a > 50% G+C content and 0.6 observed/expected ratio of CpGs (Saxonov et al., 2006; Illingworth & Bird, 2009). These islands tend to be less methylated compared to nonisland CpGs and are often associated with gene promoters, while the regions immediately surrounding CpG islands are referred to as ‘shores’, followed by ‘shelves’. Approximately 60–70% of genes have a CpG island associated with their promoters, and promoters can be classified according to their CpG density (Saxonov et al., 2006; Weber et al., 2007). Levels of DNA methylation at a promoter‐associated CpG island are generally negatively associated with gene expression, although some specific genes show the opposite effect (Weber et al., 2007; Lam et al., 2012; Gutierrez Arcelus et al., 2013). Interestingly, this negative correlation is not upheld when comparing expression and DNA methylation for a specific gene across individuals (van Eijk et al., 2012; Lam et al., 2012; Gutierrez Arcelus et al., 2013; Wagner et al., 2014). Conversely, DNA methylation in the gene body is often positively associated with levels of gene expression (Lister et al., 2009; Gutierrez Arcelus et al., 2013). DNA methylation also functions to repress repetitive elements, such as Alu and LINE‐1, which are generally highly methylated in the human genome. (Kochanek et al., 1993; Alves et al., 1996). Just as patterns of gene expression differ across tissues, so do patterns of DNA methylation (Byun et al., 2009; Ziller et al., 2013). In fact, tissue of origin is the primary difference in DNA methylation profiles from different samples, regardless of whether they originate from the same or different individuals (Davies et al., 2012; Ziller et al., 2013; Jiang et al., 2015). DNA methylation can affect transcription factor binding sites, insulator elements, and chromatin conformation, resulting in multiple levels of control of expression (reviewed in (Jones, 2012)). In addition to normal DNA methylation, variations and derivatives of the methyl mark on CpG dinucleotides have also been reported, including hydroxymethyl, formyl, and carboxyl groups, as well as methyl marks that occur at non‐CpG sites. These variants are very rare and many of the technologies commonly used to assess DNA methylation do not distinguish between them, and so for the purposes of this review, all such modifications to DNA will be referred to as ‘DNA methylation’. Recently, there has been an increase in the number of studies examining associations between DNA methylation in age across the lifespan and across tissues. In this review, we outline the dynamics of DNA methylation over the lifespan and define two distinct phenomena that collectively contribute to these changes. We focus only on healthy aging; for excellent reviews of the epigenetics of age‐associated disease including cancer, please see Baylin & Jones (2011), Bergman & Cedar (2013), and Teschendorff et al. (2013). DNA METHYLATION DYNAMICS DURING AGING Changes in DNA methylation occur throughout the lifetime, beginning at conception. Early studies assessing levels of DNA methylation both globally and at specific regions observed age‐associated changes (Wilson et al., 1987; Drinkwater et al., 1989; Fuke et al., 2004; Kwabi‐Addo et al., 2007). These studies examined DNA methylation through assessment of global methylcytosine/cytosine ratios by immune, colorimetric, and HPLC analyses, and occasionally by assaying DNA methylation at repetitive elements. Based on these early studies, it was hypothesized that DNA methylation was not accurately maintained over cell divisions, resulting in a gradual loss and increase in variability over the lifespan (Cooney, 1993). This phenomenon has been referred to as ‘epigenetic drift’ (Egger et al., 2004; Martin, 2005). More recent work has shown that both Alu and LINE‐1 repetitive elements exhibit decreased DNA methylation levels and increased variability with age (Bollati et al., 2009; Talens et al., 2012). Furthermore, samples from the same individuals taken 8 years later showed that Alu elements lose methylation longitudinally, further verifying this pattern (Bollati et al., 2009). Together, these data demonstrate that gradual change in DNA methylation occurs with age, both generally across the genome and specifically at repetitive elements. With the advent of microarray technology, it became possible